Some studies showed that tumor-infiltrating FOXP3+ T cells have been associated with poor prognosis, consistent with the initial hypothesis that FOXP3+Treg inhibit antitumor immunity [2], [4]; while other studies found that FOXP3+ T cells are associated with a favorable prognosis [2], [4]. The gene discussed is FOXP3; the disease is neoplasm.